azathioprine has been researched along with Glomerulonephritis, Membranous in 26 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Glomerulonephritis, Membranous: A type of glomerulonephritis that is characterized by the accumulation of immune deposits (COMPLEMENT MEMBRANE ATTACK COMPLEX) on the outer aspect of the GLOMERULAR BASEMENT MEMBRANE. It progresses from subepithelial dense deposits, to basement membrane reaction and eventual thickening of the basement membrane.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The treatment of membranous lupus nephritis (MLN) is still controversial in the literature." | 5.37 | Prednisone monotherapy induced remission in a group of patients with membranous lupus nephritis. ( Alves de Brito, G; Bitencourt Dias, C; Dos Santos Silva, V; Gera Abrão, J; Malafronte, P; Pinheiro, CC; Titan, S; Toledo Barros, R; Woronik, V, 2011) |
| "Progressive passive Heymann nephritis (group II) was induced in rats by i." | 5.28 | Accelerated passive Heymann nephritis in rats as an experimental model for membranous glomerulonephritis and effects of azathioprine and prednisolone on the nephritis. ( Aono, Y; Ito, M; Nagamatsu, T; Suzuki, A; Suzuki, Y, 1989) |
| " The effect of treatment with prednisolone and azathioprine in patients with nephrotic-range proteinuria and biopsy-proven IMN from a single center (Sheffield Kidney Institute, Sheffield, UK) is described." | 3.70 | Does immunosuppression with prednisolone and azathioprine alter the progression of idiopathic membranous nephropathy? ( Ahuja, M; Brown, CB; Gerakis, A; Goumenos, D; Shortland, JR, 1999) |
| " Forty of them, who presented a nephrotic syndrome, were treated by immunosuppressive drugs (prednisone, azathioprine, chlorambucil, cyclophosphamide) for 79 +/- 9." | 3.67 | Long-term immunosuppressive therapy of idiopathic membranoproliferative glomerulonephritis. ( Glyda, J; Gradowska, L; Juskowa, J; Klepacka, J; Lao, M; Morzycka-Michalik, M; Orlowski, T; Rancewicz, Z, 1988) |
| "Optimal treatment for pure membranous lupus nephritis (MLN) remains unknown." | 2.82 | Immunosuppressive treatment for pure membranous lupus nephropathy in a Hispanic population. ( Córdova-Sánchez, BM; Correa-Rotter, R; Mejía-Vilet, JM; Uribe-Uribe, NO, 2016) |
| "A fall in proteinuria was recorded in both groups during treatment, but it rose significantly in Aza group (1." | 2.76 | Cyclosporine versus azathioprine therapy in high-risk idiopathic membranous nephropathy patients: A 3-year prospective study. ( Basta-Jovanovic, G; Jovanovic, D; Marinkovic, J; Naumovic, R; Pavlovic, S; Stosovic, M, 2011) |
| " Retreatment with an augmented dosage of prednisolone, +/- another immunosuppressive agent, resulted in CR and PR in 15 (79%) and 4 (21%) of these flare episodes, respectively." | 2.74 | Very long-term outcome of pure lupus membranous nephropathy treated with glucocorticoid and azathioprine. ( Mok, CC; Ng, WL; Wong, WS; Yim, CW; Ying, KY, 2009) |
| "Primary membranous nephropathy (PMN) is a common cause of nephrotic syndrome in adults." | 2.72 | Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome. ( Au, EH; Chen, Y; Hodson, EM; Mathew, AT; Tunnicliffe, DJ; von Groote, TC; Williams, G, 2021) |
| "Proteinuria has significantly reduced in 10 patients, and only four patients still have nephrotic-range proteinuria." | 2.69 | Treatment of renal failure in idiopathic membranous nephropathy with azathioprine and prednisolone. ( Brown, JH; Doherty, CC; Douglas, AF; Hill, CM; McNamee, PT; Murphy, BG; Nelson, WE, 1998) |
| "Overlap syndrome is the combination of autoimmune liver diseases, and this term usually describes the coexistence of autoimmune hepatitis (AIH) and primary biliary cirrhosis (PBC) in the same patient." | 1.91 | Coexistence of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome and membranous nephropathy: A case report. ( Chen, H; Gao, X; Hong, X; Hu, S; Jin, X; Qiao, Z; Xia, C; Xiang, X; Xu, Y; Zhang, P, 2023) |
| "LON was not observed in minimal change disease or focal segmental glomerulosclerosis." | 1.62 | Incidence, Clinical Features, and Outcomes of Late-Onset Neutropenia From Rituximab for Autoimmune Disease. ( Cortazar, FB; Huizenga, NR; Laliberte, K; Niles, JL; Rhee, EP; Rosenthal, JM; Wallace, ZS; Zonozi, R, 2021) |
| "Suggestion for the management of idiopathic membranous nephropathy (IMN) includes 6 months of observation, followed with steroid plus alkylating agent." | 1.46 | Early initiation of immunosuppressive treatment in membranous nephropathy patients. ( Chan, CK; Chen, PM; Chen, YM; Chiang, WC; Chiu, YL; Chou, YH; Chu, TS; Lai, TS; Wu, CF; Wu, KD, 2017) |
| "Membranous nephropathy is a common cause of nephrotic syndrome in adults." | 1.40 | Membranous nephropathy with crescents in a patient with Hashimoto's thyroiditis: a case report. ( Bracamonte, E; John, SG; Ossai, NO; Riaz, IB; Sussman, AN; Thajudeen, B, 2014) |
| "The treatment of membranous lupus nephritis (MLN) is still controversial in the literature." | 1.37 | Prednisone monotherapy induced remission in a group of patients with membranous lupus nephritis. ( Alves de Brito, G; Bitencourt Dias, C; Dos Santos Silva, V; Gera Abrão, J; Malafronte, P; Pinheiro, CC; Titan, S; Toledo Barros, R; Woronik, V, 2011) |
| "Chronic ulcerative colitis can be associated with glomerulonephritis." | 1.33 | Membranous nephropathy associated with familial chronic ulcerative colitis in a 12-year-old girl. ( Gordjani, N; Gröne, HJ; Kiss, E; Kreth, HW; Ridder, RM, 2005) |
| "Treatment with prednisolone and azathioprine seems to be of no long-term benefit in ameliorating the clinical course of nephrotic patients with membranous nephropathy." | 1.33 | Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study. ( Ahuja, M; Brown, CB; Davlouros, P; El Nahas, AM; Goumenos, DS, 2006) |
| " Over 20 years, we have simply observed our patients clinically after diagnosis, and only used aggressive therapy with steroids in high dosage and azathioprine for 21 patients with progressive renal failure." | 1.30 | 'Progressive' versus 'indolent' idiopathic membranous glomerulonephritis. ( Bone, JM; Rustom, R; Williams, PS, 1997) |
| "Progressive passive Heymann nephritis (group II) was induced in rats by i." | 1.28 | Accelerated passive Heymann nephritis in rats as an experimental model for membranous glomerulonephritis and effects of azathioprine and prednisolone on the nephritis. ( Aono, Y; Ito, M; Nagamatsu, T; Suzuki, A; Suzuki, Y, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (11.54) | 18.7374 |
| 1990's | 10 (38.46) | 18.2507 |
| 2000's | 3 (11.54) | 29.6817 |
| 2010's | 6 (23.08) | 24.3611 |
| 2020's | 4 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| von Groote, TC | 1 |
| Williams, G | 1 |
| Au, EH | 1 |
| Chen, Y | 1 |
| Mathew, AT | 1 |
| Hodson, EM | 1 |
| Tunnicliffe, DJ | 1 |
| Hong, X | 1 |
| Hu, S | 1 |
| Zhang, P | 1 |
| Gao, X | 1 |
| Qiao, Z | 1 |
| Xia, C | 1 |
| Xu, Y | 1 |
| Jin, X | 1 |
| Xiang, X | 1 |
| Chen, H | 1 |
| Zonozi, R | 1 |
| Wallace, ZS | 1 |
| Laliberte, K | 1 |
| Huizenga, NR | 1 |
| Rosenthal, JM | 1 |
| Rhee, EP | 1 |
| Cortazar, FB | 1 |
| Niles, JL | 1 |
| Zickert, A | 1 |
| Lannfelt, K | 1 |
| Schmidt Mende, J | 1 |
| Sundelin, B | 1 |
| Gunnarsson, I | 1 |
| Thajudeen, B | 1 |
| John, SG | 1 |
| Ossai, NO | 1 |
| Riaz, IB | 1 |
| Bracamonte, E | 1 |
| Sussman, AN | 1 |
| Mejía-Vilet, JM | 1 |
| Córdova-Sánchez, BM | 1 |
| Uribe-Uribe, NO | 1 |
| Correa-Rotter, R | 1 |
| Chan, CK | 1 |
| Lai, TS | 1 |
| Chen, PM | 1 |
| Chou, YH | 1 |
| Wu, CF | 1 |
| Chiu, YL | 1 |
| Chiang, WC | 1 |
| Chen, YM | 1 |
| Chu, TS | 1 |
| Wu, KD | 1 |
| Mok, CC | 1 |
| Ying, KY | 1 |
| Yim, CW | 1 |
| Ng, WL | 1 |
| Wong, WS | 1 |
| Naumovic, R | 1 |
| Jovanovic, D | 1 |
| Pavlovic, S | 1 |
| Stosovic, M | 1 |
| Marinkovic, J | 1 |
| Basta-Jovanovic, G | 1 |
| Bitencourt Dias, C | 1 |
| Pinheiro, CC | 1 |
| Malafronte, P | 1 |
| Titan, S | 1 |
| Alves de Brito, G | 1 |
| Gera Abrão, J | 1 |
| Dos Santos Silva, V | 1 |
| Toledo Barros, R | 1 |
| Woronik, V | 1 |
| Yumura, W | 1 |
| Ridder, RM | 1 |
| Kreth, HW | 1 |
| Kiss, E | 1 |
| Gröne, HJ | 1 |
| Gordjani, N | 1 |
| Goumenos, DS | 1 |
| Ahuja, M | 2 |
| Davlouros, P | 1 |
| El Nahas, AM | 1 |
| Brown, CB | 2 |
| Baker, LR | 3 |
| Tucker, B | 3 |
| Macdougall, IC | 3 |
| Raine, AE | 1 |
| Crowe, AV | 1 |
| Raman, GV | 1 |
| Turner, AM | 1 |
| Konishi, T | 1 |
| Miki, S | 1 |
| Yoshida, A | 1 |
| Tei, M | 1 |
| Bone, JM | 1 |
| Rustom, R | 1 |
| Williams, PS | 1 |
| Oommen, R | 2 |
| Brown, JH | 1 |
| Douglas, AF | 1 |
| Murphy, BG | 1 |
| Hill, CM | 1 |
| McNamee, PT | 1 |
| Nelson, WE | 1 |
| Doherty, CC | 1 |
| Goto, T | 1 |
| Komatsu, M | 1 |
| Fujii, T | 1 |
| Ohshima, S | 1 |
| Nakane, K | 1 |
| Yoneyama, K | 1 |
| Shibuya, T | 1 |
| Meng, XW | 1 |
| Masamune, O | 1 |
| Imai, H | 1 |
| Klein, M | 1 |
| Radhakrishnan, J | 1 |
| Appel, G | 1 |
| Goumenos, D | 1 |
| Shortland, JR | 1 |
| Gerakis, A | 1 |
| Ito, M | 1 |
| Aono, Y | 1 |
| Suzuki, A | 1 |
| Nagamatsu, T | 1 |
| Suzuki, Y | 1 |
| Orlowski, T | 1 |
| Rancewicz, Z | 1 |
| Lao, M | 1 |
| Juskowa, J | 1 |
| Klepacka, J | 1 |
| Gradowska, L | 1 |
| Morzycka-Michalik, M | 1 |
| Glyda, J | 1 |
| Fujimoto, S | 1 |
| Yamamoto, Y | 1 |
| Wakisaka, O | 1 |
| Hisanaga, S | 1 |
| Miyata, J | 1 |
| Tanaka, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| an Open Parallel Clinical Trial in HBV-GN Patients[NCT01152060] | 10 participants (Anticipated) | Observational | 2010-01-31 | Active, not recruiting | |||
| European Multicenter and Open-Label Controlled Randomized Trial to Evaluate the Efficacy of Sequential Treatment With Tacrolimus-Rituximab Versus Steroids Plus Cyclophosphamide in Patients With Primary Membranous Nephropathy (The STARMEN Study)[NCT01955187] | Phase 3 | 86 participants (Actual) | Interventional | 2014-01-31 | Completed | ||
| Mycophenolate Mofetil and Tacrolimus vs Tacrolimus Alone for the Treatment of Idiopathic Membranous Glomerulonephritis (IMG)[NCT00843856] | Phase 4 | 40 participants (Actual) | Interventional | 2009-03-03 | Completed | ||
| A Prospective Randomized Open-label Study to Compare Mycophenolate Mofetil and Corticosteroid With Conventional Immunosuppressive Treatment on Proteinuria in Idiopathic Membranous Nephropathy (MN) and Focal Segmental Glomerulosclerosis (FSGS)[NCT00404833] | Phase 3 | 16 participants (Anticipated) | Interventional | 2003-01-31 | Completed | ||
| A Dose-Finding Pilot Study of ACTH on the Serum Lipoprotein Profile and Proteinuria in Patients With Idiopathic Membranous Nephropathy (MN)[NCT00805753] | Phase 1 | 20 participants (Actual) | Interventional | 2009-01-31 | Completed | ||
| Treatment of Patients With Idiopathic Membranous Nephropathy at Risk for Renal Insufficiency: Comparison of Early Versus Late Start of Immunosuppressive Therapy[NCT00135954] | Phase 3 | 29 participants (Actual) | Interventional | 1997-07-31 | Completed | ||
| A Randomized, Placebo-Controlled, Parallel-Group, Double-Blind Study of H.P. Acthar Gel (Acthar) in Treatment-Resistant Subjects With Persistent Proteinuria and Nephrotic Syndrome Due to Idiopathic Membranous Nephropathy (iMN)[NCT01386554] | Phase 4 | 60 participants (Actual) | Interventional | 2011-08-31 | Completed | ||
| A Randomized Controlled Trial of Rituximab Versus Steroids and Cyclophosphamide in the Treatment of Idiopathic Membranous Nephropathy[NCT03018535] | Phase 3 | 76 participants (Actual) | Interventional | 2012-01-31 | Active, not recruiting | ||
| Tacrolimus Treatment of Patients With Idiopathic[NCT00302523] | 16 participants (Actual) | Interventional | 2006-03-31 | Completed | |||
| To Compare the Efficacy and Safety of TW vs Valsartan in the MN[NCT00518219] | Phase 4 | 68 participants (Actual) | Interventional | 2007-07-31 | Completed | ||
| A Dose-finding Pilot Study of ACTH (Adrenocorticotropic Hormone) on the Proteinuria and Serum Lipoprotein Profile in Patients With Idiopathic Membranous Nephropathy (MN)[NCT01093157] | Phase 1/Phase 2 | 10 participants (Actual) | Interventional | 2010-02-28 | Completed | ||
| Phase 3 Study of Tacrolimus Combined With Prednisone Treatment of Idiopathic Membranous Nephropathy and Nephrotic Syndrome[NCT00362531] | Phase 2/Phase 3 | 0 participants | Interventional | 2004-11-30 | Completed | ||
| A Randomized Controlled Multi-center Trial of Mycophenolate Mofetil for the Patient With High Risk Membranous Nephropathy[NCT01282073] | Phase 3 | 62 participants (Anticipated) | Interventional | 2011-03-31 | Recruiting | ||
| Opportunity, Validity and Security of Steroids Plus Cyclosporin Therapy for Patients of Idiopathic Membranous Nephropathy : A Prospective, Randomized, Controlled, Multi-Center Clinical Trial[NCT02173106] | Phase 2 | 180 participants (Anticipated) | Interventional | 2014-06-30 | Recruiting | ||
| Efficacy and Safety Evaluation of QingReMoShen Granule in the Treatment of Idiopathic Membranous Nephropathy : A Randomized Double-Blind Controlled Clinical Study[NCT01845688] | 72 participants (Actual) | Interventional | 2011-11-30 | Completed | |||
| A Prospective Randomized, Controlled Trial of Mycophenolate Mofetil Plus Steroid in the Treatment Of Patients With Progressive Idiopathic Membranous Nephropathy[NCT03170323] | Phase 4 | 128 participants (Anticipated) | Interventional | 2018-07-01 | Recruiting | ||
| Prospective Randomized Multicentric Open Label Study to Evaluate Rituximab Treatment for Idiopathic Membranous Nephropathy (IMN)[NCT01508468] | Phase 3 | 80 participants (Actual) | Interventional | 2012-01-17 | Completed | ||
| "A Randomized Controlled Trial of Rituximab Versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (IMN)"[NCT01180036] | Phase 2/Phase 3 | 130 participants (Actual) | Interventional | 2011-11-30 | Completed | ||
| BEL114674: A 2 Year Study of Efficacy and Safety of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous Nephropathy[NCT01762852] | Phase 2 | 0 participants (Actual) | Interventional | 2013-04-30 | Withdrawn (stopped due to Withdrawn due to difficulties in to recruiting due to competing studies, changing treatment practices, unavailability of eligible study population) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Efficacy of mycophenolate in preventing relapse of nephrotic syndrome secondary to membranous glomerulonephritis on withdrawal of tacrolimus therapy. (NCT00843856)
Timeframe: 10-109 weeks
| Intervention | Participants (Count of Participants) |
|---|---|
| Tacrolimus | 8 |
| Tacrolimus and Mycophenolate Mofetil | 8 |
The degree of remission of proteinuria obtained (complete or partial) The rate of decline of renal function measured by the Modification of Diet in Renal Disease equation for glomerular filtration rate. (NCT00843856)
Timeframe: 6-12 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Tacrolimus | 16 |
| Tacrolimus and Mycophenolate Mofetil | 19 |
The participant's response was considered the average of the two PCR values from the 24-hour urine collections at Visit 8 (Week 24). (NCT01386554)
Timeframe: At Visit 9 (Week 28)
| Intervention | Participants (Count of Participants) |
|---|---|
| Acthar 40U | 1 |
| Acthar 80U | 4 |
| Combined Placebo | 2 |
The participant's response was considered the average of the two PCR values from the 24-hour urine collected at Visit 8 (Week 24). Urine protein creatinine ratio (uPCR) was used to assess remission (partial and complete). Complete remission = uPCR < 0.3 g/g; partial remission = uPCR < 50% of baseline uPCR and > 0.3 g/g but < 3.0 g/g. (NCT01386554)
Timeframe: At Visit 8 (Week 24)
| Intervention | Participants (Count of Participants) | |
|---|---|---|
| Partial remission in proteinuria | Complete remission in proteinuria | |
| Acthar 40U | 1 | 0 |
| Acthar 80U | 5 | 0 |
| Combined Placebo | 2 | 0 |
The number of subjects to reach either complete remission or partial remission at 12 months after randomization. (NCT01180036)
Timeframe: 12 months after randomization
| Intervention | Participants (Count of Participants) |
|---|---|
| Rituximab Treatment Arm | 39 |
| Cyclosporine Treatment Arm | 34 |
The number of subjects to reach the composite of maintaining complete remission or partial remission at 24 months after randomization will be the primary endpoint. (NCT01180036)
Timeframe: 24 months after randomization
| Intervention | Participants (Count of Participants) |
|---|---|
| Rituximab Treatment Arm | 39 |
| Cyclosporine Treatment Arm | 13 |
3 reviews available for azathioprine and Glomerulonephritis, Membranous
| Article | Year |
|---|---|
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephro | 2021 |
[Secondary membranous nephropathy: The topics of membranous lupus nephritis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Calcineurin Inhibitors; Drug Therapy, | 2011 |
Cyclosporine treatment of glomerular diseases.
Topics: Autoimmune Diseases; Azathioprine; Cyclosporine; Drug Combinations; Glomerulonephritis; Glomerulonep | 1999 |
5 trials available for azathioprine and Glomerulonephritis, Membranous
| Article | Year |
|---|---|
Immunosuppressive treatment for pure membranous lupus nephropathy in a Hispanic population.
Topics: Adolescent; Adult; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Female; Glomerulonephr | 2016 |
Very long-term outcome of pure lupus membranous nephropathy treated with glucocorticoid and azathioprine.
Topics: Adult; Azathioprine; Creatinine; Female; Glomerulonephritis, Membranous; Glucocorticoids; Humans; Im | 2009 |
Cyclosporine versus azathioprine therapy in high-risk idiopathic membranous nephropathy patients: A 3-year prospective study.
Topics: Adult; Azathioprine; Cyclosporine; Female; Follow-Up Studies; Glomerulonephritis, Membranous; Humans | 2011 |
Treatment of idiopathic membranous nephropathy.
Topics: Azathioprine; Creatinine; Drug Therapy, Combination; Glomerulonephritis, Membranous; Humans; Prednis | 1994 |
Treatment of renal failure in idiopathic membranous nephropathy with azathioprine and prednisolone.
Topics: Adolescent; Adult; Aged; Azathioprine; Disease Progression; Female; Glomerulonephritis, Membranous; | 1998 |
18 other studies available for azathioprine and Glomerulonephritis, Membranous
| Article | Year |
|---|---|
Coexistence of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome and membranous nephropathy: A case report.
Topics: Azathioprine; Glomerulonephritis, Membranous; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliar | 2023 |
Incidence, Clinical Features, and Outcomes of Late-Onset Neutropenia From Rituximab for Autoimmune Disease.
Topics: Adult; Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Asymptomatic Diseases; Auto | 2021 |
Resorption of immune deposits in membranous lupus nephritis following rituximab vs conventional immunosuppressive treatment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antigen-Antibody Complex; Azathioprine; Female; Glomerul | 2021 |
Membranous nephropathy with crescents in a patient with Hashimoto's thyroiditis: a case report.
Topics: Adult; Azathioprine; Cyclophosphamide; Glomerulonephritis; Glomerulonephritis, Membranous; Hashimoto | 2014 |
Early initiation of immunosuppressive treatment in membranous nephropathy patients.
Topics: Adult; Aged; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Glomer | 2017 |
Prednisone monotherapy induced remission in a group of patients with membranous lupus nephritis.
Topics: Adult; Azathioprine; Creatinine; Cyclophosphamide; Drug Therapy, Combination; Female; Glomerulonephr | 2011 |
Membranous nephropathy associated with familial chronic ulcerative colitis in a 12-year-old girl.
Topics: Azathioprine; Child; Colitis, Ulcerative; Female; Glomerulonephritis, Membranous; Humans; Immunosupp | 2005 |
Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
Topics: Adult; Aged; Azathioprine; Creatinine; Drug Therapy, Combination; Female; Follow-Up Studies; Glomeru | 2006 |
Membranous nephropathy associated with an inflammatory myelopathy.
Topics: Azathioprine; Drug Therapy, Combination; Glomerulonephritis, Membranous; Humans; Male; Middle Aged; | 1996 |
[A post-thymomectomy case of myasthenia gravis which developed nephrotic syndrome with membranous nephropathy during azathioprine administration].
Topics: Azathioprine; Combined Modality Therapy; Female; Glomerulonephritis, Membranous; Glucocorticoids; Hu | 1996 |
'Progressive' versus 'indolent' idiopathic membranous glomerulonephritis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Azathioprine; Clinical Protocols; Drug Adm | 1997 |
Treatment of progressive renal failure and nephrotic syndrome with azathioprine and prednisolone.
Topics: Anti-Inflammatory Agents; Azathioprine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Ag | 1997 |
Treatment of progressive renal failure in idiopathic membranous nephropathy with azathioprine and prednisolone.
Topics: Azathioprine; Disease Progression; Follow-Up Studies; Glomerulonephritis, Membranous; Glucocorticoid | 1998 |
Primary biliary cirrhosis associated with membranous glomerulonephritis.
Topics: Adult; Azathioprine; Biopsy; Cholagogues and Choleretics; Diagnosis, Differential; Dipyridamole; Dru | 1999 |
Does immunosuppression with prednisolone and azathioprine alter the progression of idiopathic membranous nephropathy?
Topics: Adult; Aged; Azathioprine; Biopsy; Female; Follow-Up Studies; Glomerulonephritis, Membranous; Humans | 1999 |
Accelerated passive Heymann nephritis in rats as an experimental model for membranous glomerulonephritis and effects of azathioprine and prednisolone on the nephritis.
Topics: Animals; Azathioprine; Disease Models, Animal; Glomerulonephritis; Glomerulonephritis, Membranous; K | 1989 |
Long-term immunosuppressive therapy of idiopathic membranoproliferative glomerulonephritis.
Topics: Adult; Azathioprine; Chlorambucil; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-Up St | 1988 |
[Long-term outcome of nephrotic syndrome due to primary membranous nephropathy].
Topics: Adult; Aged; Azathioprine; Cyclophosphamide; Female; Glomerulonephritis, Membranous; Humans; Male; M | 1988 |